Detalhe da pesquisa
1.
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Blood
; 138(7): 531-543, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33851211
2.
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
Blood Adv
; 5(17): 3397-3406, 2021 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34432870
3.
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
Blood Adv
; 4(4): 676-686, 2020 02 25.
Artigo
Inglês
| MEDLINE | ID: mdl-32084260